Despite still being alterable by “classical” IFN or NFκB signaling, our findings indicate upregulation of IFIT3 without an adequate inflammatory stimulus in the more aggressive pancreatic cancer cell line. This evidence concerns the gene NFKB1 and pancreatic neoplasm.